PMV Pharmaceuticals Files 10-Q for Q1 2025
Ticker: PMVP · Form: 10-Q · Filed: May 9, 2025 · CIK: 1699382
| Field | Detail |
|---|---|
| Company | Pmv Pharmaceuticals, Inc. (PMVP) |
| Form Type | 10-Q |
| Filed Date | May 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
PMV Pharma's Q1 2025 10-Q is in. Check financials.
AI Summary
PMV Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. Key financial data and strategic initiatives are presented for the reporting quarter.
Why It Matters
This filing provides investors with the latest financial health and operational status of PMV Pharmaceuticals, crucial for understanding its current trajectory and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, PMV Pharmaceuticals is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- Q1 2025 — Reporting Period (The period covered by the 10-Q filing.)
- March 31, 2025 — End Date (The specific date the financial period concluded.)
Key Players & Entities
- PMV Pharmaceuticals, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 0000950170-25-067513 (filing_id) — Accession number for the filing
- Princeton, NJ (location) — Business and mailing address
FAQ
What is the accession number for this 10-Q filing?
The accession number is 0000950170-25-067513.
What is the company's full name as per the filing?
The company's full name is PMV Pharmaceuticals, Inc.
What is the fiscal year end for PMV Pharmaceuticals?
The fiscal year end is December 31.
What is the business address of PMV Pharmaceuticals?
The business address is 400 Alexander Park Drive, Suite 301, Princeton, NJ 08540.
What is the SIC code for PMV Pharmaceuticals?
The Standard Industrial Classification code is 2834, for Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding PMV Pharmaceuticals, Inc. (PMVP).